Höflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Döcke W, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood. 2004;103:673–5.
Döffinger R, Helbert M, Barcenas-Morales G, Yang K, Dupuis S, Ceron-Gutierrez L, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38:e10-14.
Lin C, Chi C, Shih H, Ding J, Lo C, Wang S, et al. Identification of a major epitope by anti-interferon-γ autoantibodies in patients with mycobacterial disease. Nat Med. 2016;22:994–1001.
Article CAS PubMed Google Scholar
Browne S, Zaman R, Sampaio E, Jutivorakool K, Rosen L, Ding L, et al. Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood. 2012;119:3933–9.
Article CAS PubMed PubMed Central Google Scholar
Chen ZM, Yang XY, Li ZT, Guan WJ, Qiu Y, Li SQ, et al. Anti-interferon-gamma autoantibodies impair T-lymphocyte responses in patients with Talaromyces marneffei infections. Infect Drug Resist. 2022;15:3381–93.
Article PubMed PubMed Central Google Scholar
Browne S, Burbelo P, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Eng J Med. 2012;367:725–34.
Wu U, Hung C, Chang S, Jhong Y, Sun H, Wang J, et al. Neutralizing antiinterferon-γ autoantibodies causing disseminated Mycobacterium avium complex infection in an HIV-infected patient on successful combination antiretroviral therapy. AIDS. 2017;31:2557–9.
Article CAS PubMed Google Scholar
Hong G, Ortega-Villa A, Hunsberger S, Chetchotisakd P, Anunnatsiri S, Mootsikapun P, et al. Natural history and evolution of anti-interferon-γ autoantibody-associated immunodeficiency syndrome in Thailand and the United States. Clin Infect Dis. 2020;71:53–62.
Article CAS PubMed Google Scholar
Ku CL, Lin CH, Chang SW, Chu CC, Chan JF, Kong XF, et al. Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia. J Allergy Clin Immunol. 2016;137(945–948):e948.
Chi C, Chu C, Liu J, Lin C, Ho M, Lo W, et al. Anti-IFN-γ autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121:1357–66.
Article CAS PubMed Google Scholar
Oka K, Yamane M, Yokota Y, Yasuda M, Hasegawa K, Fujimori T, et al. Disseminated Mycobacterium genavense infection mimicking TAFRO syndrome. J Infect Chemother. 2020;26:1095–9.
Article CAS PubMed Google Scholar
King Y, Hu C, Lee Y, Lin C, Liu D, Wang K. Disseminated cutaneous Mycobacterium kansasii infection presenting with Rosai-Dorfman disease-like histological features in a patient carrying anti-interferon-γ autoantibodies. J Dermatol. 2017;44:1396–400.
Article CAS PubMed Google Scholar
Furuya H, Ikeda K, Miyachi K, Nakamura K, Suzuki K, Furuta S, et al. SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody. Rheumatology. 2017;56:1241–3.
Koizumi Y, Sakagami T, Minamiguchi H, Makino A, Aoki A, Hodohara K, et al. Chylous ascites, anti-interferon-gamma autoantibody, and angioimmunoblastic T-cell lymphoma: a rare but intriguing connection over Mycobacterium avium. Med Microbiol Immunol. 2019;208:33–7.
Article CAS PubMed Google Scholar
Liu TT, Weng SW, Wang MC, Huang WT. Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy. APMIS. 2016;124:216–20.
Article CAS PubMed Google Scholar
Angkasekwinai N, Suputtamongkol Y, Phoompoung P, Pithukpakorn M, Wongswat E, Umrod P, et al. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies. PLoS ONE. 2019;14:e0215581.
Article CAS PubMed PubMed Central Google Scholar
Boyle S, Hagiya A, Nguyen MH, Liebman H, Lee JSG. The unique diagnostic and management challenge of a patient with concomitant anti-interferon-gamma autoantibody associated immunodeficiency syndrome, IgG4-related disease, and treatment refractory, disseminated mycobacterium avium complex infection. Allergy Asthma Clin Immunol. 2022;18:82.
Article PubMed PubMed Central Google Scholar
Namkoong H, Asakura T, Ishii M, Yoda S, Masaki K, Sakagami T, et al. First report of hepatobiliary infection developing obstructive jaundice in a patient with neutralizing anti-interferon-gamma autoantibodies. New Microbes New Infect. 2019;27:4–6.
Article CAS PubMed Google Scholar
King EM, Weaver VK, Kestler MH. Treatment dilemmas in disseminated nontuberculous mycobacterial infections with interferon-gamma autoantibodies. Open Forum Infect Dis. 2021;8:ofab253.
Article PubMed PubMed Central Google Scholar
Pruetpongpun N, Khawcharoenporn T, Damronglerd P, Suthiwartnarueput W, Apisarnthanarak A, Rujanavej S, et al. Disseminated Talaromyces marneffei and Mycobacterium abscessus in a patient with anti-interferon-γ autoantibodies. Open Forum Infect Dis. 2016;3:ofw093.
Article PubMed PubMed Central Google Scholar
Laisuan W, Pisitkun P, Ngamjanyaporn P, Suangtamai T, Rotjanapan P. Prospective Pilot Study of Cyclophosphamide as an Adjunct Treatment in Patients With Adult-Onset Immunodeficiency Associated With Anti-interferon-gamma Autoantibodies. Open Forum Infect Dis. 2020;7:ofaa035.
Article PubMed PubMed Central Google Scholar
Rocco JM, Rosen LB, Hong GH, Treat J, Zerbe CS. Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies. J Transl Autoimmun. 2021;4:100102.
Article CAS PubMed PubMed Central Google Scholar
Zeitler K, Walter J, Khan F, Sriaroon C. Recurrent disseminated Mycobacterium avium in a female patient from Thailand with anti-interferon-gamma autoantibodies: dilemma on treatment approach. BMJ Case Rep. 2021;14:e237909.
Article PubMed PubMed Central Google Scholar
Roerden M, Döffinger R, Barcenas-Morales G, Forchhammer S, Döbele S, Berg C. Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies. BMC Infect Dis. 2020;20:828.
Article CAS PubMed PubMed Central Google Scholar
Saba M, Greene JN. Refractory mycobacterium avium complex pneumonia and anti-interferon-gamma autoantibodies: a case report. Infect Dis Clin Pract. 2019;27:110–3.
Daley AS, Naro GR, Craig TJ, Hussein RHA, Banjade R, Jacobs JB, et al. POPS case: a 30-year-old Filipino woman with fevers, lymphadenopathy, painful scalp lesions, and a neck mass. Allergy Asthma Proc. 2020;41:305–8.
Ochoa S, Ding L, Kreuzburg S, Treat J, Holland S, Zerbe C. Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-interferon-γ autoantibodies. Clin Infect Dis. 2021;72:2206–8.
Chetchotisakd P, Anunnatsiri S, Nanagara R, Nithichanon A, Lertmemongkolchai G. Intravenous cyclophosphamide therapy for anti-IFN-gamma autoantibody-associated infection. J Immunol Res. 2018;2018:6473629.
Article PubMed PubMed Central Google Scholar
Harada M, Furuhashi K, Karayama M, Suzuki Y, Hozumi H, Enomoto N, et al. Subcutaneous injection of interferon gamma therapy could be useful for anti-IFN-γ autoantibody associated disseminated nontuberculous mycobacterial infection. J Infect Chemother. 2021;27:373–8.
Article CAS PubMed Google Scholar
Kampmann B, Hemingway C, Stephens A, Davidson R, Goodsall A, Anderson S, et al. Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma. J Clin Invest. 2005;115:2480–8.
Article CAS PubMed PubMed Central Google Scholar
Dahl V, Nielsen B, Wejse C, Marquart H, Bay J, von Stemann J, et al. Disseminated Mycobacterium avium complex infection in a woman with anti-interferon-γ autoantibodies. IDCases. 2021;26:e01300.
Article CAS PubMed PubMed Central Google Scholar
Kacar M, Cortes-Acevedo P, Patel V, Carter C, Hughes P, McGann HP, et al. Neutralizing anti-interferon-gamma autoantibodies: an ameliorating factor in COVID-19 infection? J Clin Immunol. 2021;41:1531–5.
Article CAS PubMed PubMed Central Google Scholar
Lin F, Yang Z, Qiu Y, Zeng W, Liu G, Zhang J. Talaromyces Marneffei infection in lung cancer patients with positive AIGAs: a rare case report. Infect Drug Resist. 2021;14:5005–13.
Article PubMed PubMed Central Google Scholar
Hanitsch LG, Lobel M, Muller-Redetzky H, Schurmann M, Suttorp N, Unterwalder N, et al. Late-onset disseminated mycobacterium avium intracellulare complex infection (MAC), cerebral toxoplasmosis and salmonella sepsis in a German Caucasian patient with unusual anti-interferon-gamma IgG1 autoantibodies. J Clin Immunol. 2015;35:361–5.
Article CAS PubMed Google Scholar
Shih HP, Ding JY, Yeh CF, Chi CY, Ku CL. Anti-interferon-gamma autoantibody-associated immunodeficiency. Curr Opin Immunol. 2021;72:206–14.
留言 (0)